Summary
29 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for ¥3.40M in the last fiscal year, 5.9% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 8.4% a year over the last 3 years.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (CNY)
Diluted EPS (CNY)
- Analyst estimate
Revenue grew by 7.0% a year over 5 years. Over the last 3 years it fell by 8.4% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of ¥106.7M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product and Service, Other 100%
By region
The company reports no revenue by region.
Product and Service, Other brings in 100% of revenue.
Segments in detail